» Articles » PMID: 36690516

Outbreak Investigation in a COVID-19 Designated Hospital: The Combination of Phylogenetic Analysis and Field Epidemiology Study Suggesting Airborne Transmission

Abstract

Background: Healthcare-associated COVID-19 infections caused by SARS-CoV-2 have increased morbidity and mortality. Hospitals and skilled nursing facilities (SNFs) have been challenged by infection control and management.

Methods: This case study presents an outbreak investigation in a COVID-19-designated hospital and a hospital-based SNF. Real-time polymerase chain reaction (PCR) and other studies were performed on samples obtained from SNF residents, hospital patients, and healthcare workers (HCWs). The results of the laboratory tests and field epidemiological data were analyzed. Genome sequencing and phylogenetic analysis of SARS-CoV-2 were performed to identify the associations between cases. The tracer gas was released and recorded by a thermal imaging camera to investigate the spatial relations within clusters.

Results: During the outbreak, 29 COVID-19 infections in 3 clusters were identified through hospital-wide, risk-guided, and symptom-driven PCR tests. This included 12 HCWs, 5 patients, and 12 SNF residents who had been hospitalized for at least 14 days. Serology tests did not identify any cases among the PCR-negative individuals. The phylogenetic analysis revealed that viral strains from the 3 clusters shared a common mutation of G3994T and were phylogenetically related, which suggested that this outbreak had a common source rather than multiple introductions from the community. Linked cases exhibited vertical spatial distribution, and the sulfur hexafluoride release test confirmed a potential airborne transmission.

Conclusions: This report addressed the advantage of a multi-disciplinary team in outbreak investigation. Identifying an airborne transmission within an outbreak highlighted the importance of regular maintenance of ventilation systems.

Citing Articles

Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection.

Lebedev M, Benjamin A, Kumar S, Molchanova N, Lin J, Koster K Pharmaceutics. 2024; 16(4).

PMID: 38675125 PMC: 11054490. DOI: 10.3390/pharmaceutics16040464.

References
1.
Goyal S, Anantharaman S, Ramakrishnan M, Sajja S, Kim S, Stanley N . Detection of viruses in used ventilation filters from two large public buildings. Am J Infect Control. 2011; 39(7):e30-8. PMC: 7132662. DOI: 10.1016/j.ajic.2010.10.036. View

2.
Parohan M, Yaghoubi S, Seraji A, Hassan Javanbakht M, Sarraf P, Djalali M . Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020; 23(5):1416-1424. DOI: 10.1080/13685538.2020.1774748. View

3.
Abbas M, Zhu N, Mookerjee S, Bolt F, Otter J, Holmes A . Hospital-onset COVID-19 infection surveillance systems: a systematic review. J Hosp Infect. 2021; 115:44-50. PMC: 8278304. DOI: 10.1016/j.jhin.2021.05.016. View

4.
Yu I, Li Y, Wong T, Tam W, Chan A, Lee J . Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004; 350(17):1731-9. DOI: 10.1056/NEJMoa032867. View

5.
Fried M, Crawford J, Mospan A, Watkins S, Munoz B, Zink R . Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States. Clin Infect Dis. 2020; 72(10):e558-e565. PMC: 7499515. DOI: 10.1093/cid/ciaa1268. View